Patent · US Active

Baculovirus expression systems

US10480010B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2012
Grant dateNov 19, 2019
Priority date
Expiry dateJul 27, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to an optimized baculovirus construct useful for the production of virus(-like) particles or viral vectors, in particular viral vectors for gene therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.